-
1
-
-
33846102093
-
Lung cancer: diagnosis and management
-
Collins L.G., Haines C., Perkel R., Enck R.E. Lung cancer: diagnosis and management. Am. Fam. Physician 2007, 75:56-63.
-
(2007)
Am. Fam. Physician
, vol.75
, pp. 56-63
-
-
Collins, L.G.1
Haines, C.2
Perkel, R.3
Enck, R.E.4
-
2
-
-
73749085492
-
Molecular interactions in cancer cell metastasis
-
Brooks S.A., Lomax-Browne H.J., Carter T.M., Kinch C.E., Hall D.M. Molecular interactions in cancer cell metastasis. Acta Histochem. 2010, 112:3-25.
-
(2010)
Acta Histochem.
, vol.112
, pp. 3-25
-
-
Brooks, S.A.1
Lomax-Browne, H.J.2
Carter, T.M.3
Kinch, C.E.4
Hall, D.M.5
-
3
-
-
33645302628
-
The epithelial-mesenchymal transition: New insights in signaling, development, and disease
-
Lee J.M., Dedhar S., Kalluri R., Thompson E.W. The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J. Cell Biol. 2006, 172:973-981.
-
(2006)
J. Cell Biol.
, vol.172
, pp. 973-981
-
-
Lee, J.M.1
Dedhar, S.2
Kalluri, R.3
Thompson, E.W.4
-
4
-
-
0036595629
-
Epithelial-mesenchymal transitions in tumour progression
-
Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 442-454
-
-
Thiery, J.P.1
-
5
-
-
62549111693
-
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies
-
Hollier B.G., Evans K., Mani S.A. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies. J. Mammary Gland Biol. Neoplasia 2009, 14:29-43.
-
(2009)
J. Mammary Gland Biol. Neoplasia
, vol.14
, pp. 29-43
-
-
Hollier, B.G.1
Evans, K.2
Mani, S.A.3
-
6
-
-
25444495269
-
Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression
-
Brabletz T., Jung A., Spaderna S., Hlubek F., Kirchner T. Opinion: migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat. Rev. Cancer 2005, 5:744-749.
-
(2005)
Nat. Rev. Cancer
, vol.5
, pp. 744-749
-
-
Brabletz, T.1
Jung, A.2
Spaderna, S.3
Hlubek, F.4
Kirchner, T.5
-
7
-
-
0037388204
-
Prospective identification of tumorigenic breast cancer cells
-
Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl. Acad. Sci. USA 2003, 100:3983-3988.
-
(2003)
Proc Natl. Acad. Sci. USA
, vol.100
, pp. 3983-3988
-
-
Al-Hajj, M.1
Wicha, M.S.2
Benito-Hernandez, A.3
Morrison, S.J.4
Clarke, M.F.5
-
8
-
-
9244241576
-
Identification of human brain tumour initiating cells
-
Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
-
(2004)
Nature
, vol.432
, pp. 396-401
-
-
Singh, S.K.1
Hawkins, C.2
Clarke, I.D.3
Squire, J.A.4
Bayani, J.5
Hide, T.6
Henkelman, R.M.7
Cusimano, M.D.8
Dirks, P.B.9
-
9
-
-
43649086456
-
Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87
-
Yu S.C., Ping Y.F., Yi L., Zhou Z.H., Chen J.H., Yao X.H., Gao L., Wang J.M., Bian X.W. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008, 265:124-134.
-
(2008)
Cancer Lett.
, vol.265
, pp. 124-134
-
-
Yu, S.C.1
Ping, Y.F.2
Yi, L.3
Zhou, Z.H.4
Chen, J.H.5
Yao, X.H.6
Gao, L.7
Wang, J.M.8
Bian, X.W.9
-
10
-
-
65349157651
-
Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens
-
Kasper S. Identification, characterization, and biological relevance of prostate cancer stem cells from clinical specimens. Urol. Oncol. 2009, 27:301-303.
-
(2009)
Urol. Oncol.
, vol.27
, pp. 301-303
-
-
Kasper, S.1
-
11
-
-
77956178360
-
EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
-
Singh A., Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene 2010, 29:4741-4751.
-
(2010)
Oncogene
, vol.29
, pp. 4741-4751
-
-
Singh, A.1
Settleman, J.2
-
12
-
-
77957969261
-
Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance
-
Wang Z., Li Y., Ahmad A., Azmi A.S., Kong D., Banerjee S., Sarkar F.H. Targeting miRNAs involved in cancer stem cell and EMT regulation: an emerging concept in overcoming drug resistance. Drug Resist. Update 2010, 13:109-118.
-
(2010)
Drug Resist. Update
, vol.13
, pp. 109-118
-
-
Wang, Z.1
Li, Y.2
Ahmad, A.3
Azmi, A.S.4
Kong, D.5
Banerjee, S.6
Sarkar, F.H.7
-
13
-
-
0032900953
-
Biochemical, cellular, and pharmacological aspects of the multidrug transporter
-
Ambudkar S.V., Dey S., Hrycyna C.A., Ramachandra M., Pastan I., Gottesman M.M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 1999, 39:361-398.
-
(1999)
Annu. Rev. Pharmacol. Toxicol.
, vol.39
, pp. 361-398
-
-
Ambudkar, S.V.1
Dey, S.2
Hrycyna, C.A.3
Ramachandra, M.4
Pastan, I.5
Gottesman, M.M.6
-
14
-
-
0036364467
-
Multidrug resistance in cancer: role of ATP-dependent transporters
-
Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 48-58
-
-
Gottesman, M.M.1
Fojo, T.2
Bates, S.E.3
-
15
-
-
52249117137
-
Defeating drug resistance in cancer
-
Gottesman M.M., Ludwig J., Xia D., Szakacs G. Defeating drug resistance in cancer. Discov. Med. 2006, 6:18-23.
-
(2006)
Discov. Med.
, vol.6
, pp. 18-23
-
-
Gottesman, M.M.1
Ludwig, J.2
Xia, D.3
Szakacs, G.4
-
16
-
-
61449247252
-
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
-
Ota S., Ishii G., Goto K., Kubota K., Kim Y.H., Kojika M., Murata Y., Yamazaki M., Nishiwaki Y., Eguchi K., Ochiai A. Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Lung Cancer 2009, 64:98-104.
-
(2009)
Lung Cancer
, vol.64
, pp. 98-104
-
-
Ota, S.1
Ishii, G.2
Goto, K.3
Kubota, K.4
Kim, Y.H.5
Kojika, M.6
Murata, Y.7
Yamazaki, M.8
Nishiwaki, Y.9
Eguchi, K.10
Ochiai, A.11
-
17
-
-
0037314795
-
RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response
-
Burger H., Foekens J.A., Look M.P., Meijer-van Gelder M.E., Klijn J.G., Wiemer E.A., Stoter G., Nooter K. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin. Cancer Res. 2003, 9:827-836.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 827-836
-
-
Burger, H.1
Foekens, J.A.2
Look, M.P.3
Meijer-van Gelder, M.E.4
Klijn, J.G.5
Wiemer, E.A.6
Stoter, G.7
Nooter, K.8
-
18
-
-
0034795256
-
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype
-
Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the sidepopulation phenotype. Nat. Med. 2001, 7:1028-1034.
-
(2001)
Nat. Med.
, vol.7
, pp. 1028-1034
-
-
Zhou, S.1
Schuetz, J.D.2
Bunting, K.D.3
Colapietro, A.M.4
Sampath, J.5
Morris, J.J.6
Lagutina, I.7
Grosveld, G.C.8
Osawa, M.9
Nakauchi, H.10
Sorrentino, B.P.11
-
19
-
-
77951596820
-
Updates in non-small cell lung cancer-insights from the 2009 45th annual meeting of the American Society of Clinical Oncology
-
Mirshahidi H.R., Hsueh C.T. Updates in non-small cell lung cancer-insights from the 2009 45th annual meeting of the American Society of Clinical Oncology. J. Hematol. Oncol. 2010, 3:18.
-
(2010)
J. Hematol. Oncol.
, vol.3
, pp. 18
-
-
Mirshahidi, H.R.1
Hsueh, C.T.2
-
20
-
-
0037236934
-
Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function
-
Hsieh J.L., Wu C.L., Lee C.H., Shiau A.L. Hepatitis B virus X protein sensitizes hepatocellular carcinoma cells to cytolysis induced by E1B-deleted adenovirus through the disruption of p53 function. Clin. Cancer Res. 2003, 9:338-345.
-
(2003)
Clin. Cancer Res.
, vol.9
, pp. 338-345
-
-
Hsieh, J.L.1
Wu, C.L.2
Lee, C.H.3
Shiau, A.L.4
-
21
-
-
44949231424
-
Analyzing real-time PCR data by the comparative C(T) method
-
Schmittgen T.D., Livak KJ K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 2008, 3:1101-1108.
-
(2008)
Nat. Protoc.
, vol.3
, pp. 1101-1108
-
-
Schmittgen, T.D.1
Livak KJ, K.J.2
-
22
-
-
0031744116
-
Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice
-
Mitsumoto M., Kamura T., Kobayashi H., Sonoda T., Kaku T., Nakano H. Emergence of higher levels of invasive and metastatic properties in the drug resistant cancer cell lines after the repeated administration of cisplatin in tumor-bearing mice. J. Cancer Res. Clin. Oncol. 1998, 124:607-614.
-
(1998)
J. Cancer Res. Clin. Oncol.
, vol.124
, pp. 607-614
-
-
Mitsumoto, M.1
Kamura, T.2
Kobayashi, H.3
Sonoda, T.4
Kaku, T.5
Nakano, H.6
-
23
-
-
70349479538
-
Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment
-
Bertolini G., Roz L., Perego P., Tortoreto M., Fontanella E., Gatti L., Pratesi G., Fabbri A., Andriani F., Tinelli S., Roz E., Caserini R., Lo Vullo S., Camerini T., Mariani L., Delia D., Calabrò E., Pastorino U., Sozzi G. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc. Natl. Acad. Sci. USA 2009, 106:16281-16286.
-
(2009)
Proc. Natl. Acad. Sci. USA
, vol.106
, pp. 16281-16286
-
-
Bertolini, G.1
Roz, L.2
Perego, P.3
Tortoreto, M.4
Fontanella, E.5
Gatti, L.6
Pratesi, G.7
Fabbri, A.8
Andriani, F.9
Tinelli, S.10
Roz, E.11
Caserini, R.12
Lo Vullo, S.13
Camerini, T.14
Mariani, L.15
Delia, D.16
Calabrò, E.17
Pastorino, U.18
Sozzi, G.19
-
24
-
-
45549107869
-
Bone metastases in lung cancer
-
Tsuya A., Fukuoka M. Bone metastases in lung cancer. Clin. Calcium 2008, 18:455-459.
-
(2008)
Clin. Calcium
, vol.18
, pp. 455-459
-
-
Tsuya, A.1
Fukuoka, M.2
-
25
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani S.A., Guo W., Liao M.J., Eaton E.N., Ayyanan A., Zhou A.Y., Brooks M., Reinhard F., Zhang C.C., Shipitsin M., Campbell L.L., Polyak K., Brisken C., Yang J., Weinberg R.A. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
Campbell, L.L.11
Polyak, K.12
Brisken, C.13
Yang, J.14
Weinberg, R.A.15
-
26
-
-
84860389952
-
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression
-
May C.D., Sphyris N., Evans K.W., Werden S.J., Guo W., Mani S.A. Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 2011, 13:202.
-
(2011)
Breast Cancer Res.
, vol.13
, pp. 202
-
-
May, C.D.1
Sphyris, N.2
Evans, K.W.3
Werden, S.J.4
Guo, W.5
Mani, S.A.6
-
27
-
-
0037277035
-
CD44 and its partners in metastasis
-
Jothy S. CD44 and its partners in metastasis. Clin. Exp. Metastasis 2003, 20:195-201.
-
(2003)
Clin. Exp. Metastasis
, vol.20
, pp. 195-201
-
-
Jothy, S.1
-
28
-
-
0029563118
-
CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas
-
Takahashi K., Stamenkovic I., Cutler M., Saya H., Tanabe K.K. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas. Oncogene 1995, 11:2223-2232.
-
(1995)
Oncogene
, vol.11
, pp. 2223-2232
-
-
Takahashi, K.1
Stamenkovic, I.2
Cutler, M.3
Saya, H.4
Tanabe, K.K.5
-
29
-
-
78649522166
-
Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties
-
Leung E.L., Fiscus R.R., Tung J.W., Tin V.P., Cheng L.C., Sihoe A.D., Fink L.M., Ma Y., Wong M.P. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties. PLoS ONE 2010, 5:e14062.
-
(2010)
PLoS ONE
, vol.5
-
-
Leung, E.L.1
Fiscus, R.R.2
Tung, J.W.3
Tin, V.P.4
Cheng, L.C.5
Sihoe, A.D.6
Fink, L.M.7
Ma, Y.8
Wong, M.P.9
-
31
-
-
6844259864
-
CD44 splice variants as prognostic markers in colorectal cancer
-
Wielenga V.J., van der Voort R., Mulder J.W., Kruyt P.M., Weidema W.F., Oosting J., Seldenrijk C.A., van Krimpen C., Offerhaus G.J., Pals S.T. CD44 splice variants as prognostic markers in colorectal cancer. Scand. J. Gastroenterol. 1998, 33:82-87.
-
(1998)
Scand. J. Gastroenterol.
, vol.33
, pp. 82-87
-
-
Wielenga, V.J.1
van der Voort, R.2
Mulder, J.W.3
Kruyt, P.M.4
Weidema, W.F.5
Oosting, J.6
Seldenrijk, C.A.7
van Krimpen, C.8
Offerhaus, G.J.9
Pals, S.T.10
-
32
-
-
77950518941
-
Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells
-
Tajima K., Ohashi R., Sekido Y., Hida T., Nara T., Hashimoto M., Iwakami S., Minakata K., Yae T., F Takahashi ., Saya H., Takahashi K. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene 2010, 29:1941-1951.
-
(2010)
Oncogene
, vol.29
, pp. 1941-1951
-
-
Tajima, K.1
Ohashi, R.2
Sekido, Y.3
Hida, T.4
Nara, T.5
Hashimoto, M.6
Iwakami, S.7
Minakata, K.8
Yae, T.9
F Takahashi, .10
Saya, H.11
Takahashi, K.12
-
33
-
-
32644467590
-
Osteopontin: role in cell signaling and cancer progression
-
Rangaswami H., Bulbule A., Kundu G.C. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol. 2006, 16:79-87.
-
(2006)
Trends Cell Biol.
, vol.16
, pp. 79-87
-
-
Rangaswami, H.1
Bulbule, A.2
Kundu, G.C.3
-
34
-
-
34548047714
-
Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer
-
Chang Y.S., Kim H.J., Chang J., Ahn C.M., Kim S.K., Kim S.K. Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer. Lung cancer 2007, 57:373-380.
-
(2007)
Lung cancer
, vol.57
, pp. 373-380
-
-
Chang, Y.S.1
Kim, H.J.2
Chang, J.3
Ahn, C.M.4
Kim, S.K.5
Kim, S.K.6
-
35
-
-
33750313208
-
Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells
-
Clarke M.F., Dick J.E., Dirks P.B., Eaves C.J., Jamieson C.H., Jones D.L., Visvader J., Weissman I.L., Wahl G.M. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006, 66:9339-9344.
-
(2006)
Cancer Res.
, vol.66
, pp. 9339-9344
-
-
Clarke, M.F.1
Dick, J.E.2
Dirks, P.B.3
Eaves, C.J.4
Jamieson, C.H.5
Jones, D.L.6
Visvader, J.7
Weissman, I.L.8
Wahl, G.M.9
-
36
-
-
33751346643
-
CD44-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
-
Sheridan C., Kishimoto H., Fuchs R.K., Mehrotra S., Bhat-Nakshatri P., Turner C.H., Goulet R., Badve S., Nakshatri H. CD44-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res. 2006, 8:R59.
-
(2006)
Breast Cancer Res.
, vol.8
-
-
Sheridan, C.1
Kishimoto, H.2
Fuchs, R.K.3
Mehrotra, S.4
Bhat-Nakshatri, P.5
Turner, C.H.6
Goulet, R.7
Badve, S.8
Nakshatri, H.9
-
37
-
-
20444397431
-
Identification of bronchioalveolar stem cells in normal lung and lung cancer
-
Kim C.F., Jackson E.L., Woolfenden A.E., Lawrence S., Babar I., Vogel S., Crowley D., Bronson R.T., Jacks T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005, 121:823-835.
-
(2005)
Cell
, vol.121
, pp. 823-835
-
-
Kim, C.F.1
Jackson, E.L.2
Woolfenden, A.E.3
Lawrence, S.4
Babar, I.5
Vogel, S.6
Crowley, D.7
Bronson, R.T.8
Jacks, T.9
-
38
-
-
79955045007
-
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer
-
Krebs M.G., Sloane R., Priest L., Lancashire L., Hou J.M., Greystoke A., Ward T.H., Ferraldeschi R., Hughes A., Clack G., Ranson M., Dive C., Blackhall F.H. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J. Clin. Oncol. 2011, 29:1556-1563.
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 1556-1563
-
-
Krebs, M.G.1
Sloane, R.2
Priest, L.3
Lancashire, L.4
Hou, J.M.5
Greystoke, A.6
Ward, T.H.7
Ferraldeschi, R.8
Hughes, A.9
Clack, G.10
Ranson, M.11
Dive, C.12
Blackhall, F.H.13
|